Independent Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
5,364
+166
+3% +$31.8K 0.02% 629
2026
Q1
$953K Sell
5,198
-616
-11% -$114K 0.02% 644
2025
Q4
$1.02M Buy
5,814
+4,386
+307% +$717K 0.02% 610
2025
Q3
$200K Buy
+1,428
New +$193K ﹤0.01% 1295
2024
Q4
Sell
-1,135
Closed -$220K 1163
2024
Q3
$220K Buy
1,135
+15
+1% +$3.14K 0.01% 1022
2024
Q2
$260K Sell
1,120
-11
-1% -$2.39K 0.01% 897
2024
Q1
$244K Buy
1,131
+225
+25% +$52.7K 0.01% 881
2023
Q4
$234K Buy
906
+30
+3% +$7.37K 0.01% 832
2023
Q3
$225K Sell
876
-80
-8% -$21.4K 0.01% 785
2023
Q2
$272K Hold
956
0.02% 680
2023
Q1
$266K Sell
956
-299
-24% -$82.7K 0.02% 662
2022
Q4
$348K Buy
1,255
+50
+4% +$14.1K 0.03% 522
2022
Q3
$322K Sell
1,205
-211
-15% -$44.8K 0.03% 518
2022
Q2
$289K Buy
1,416
+53
+4% +$10.8K 0.03% 515
2022
Q1
$287K Buy
1,363
+210
+18% +$45.7K 0.02% 612
2021
Q4
$277K Buy
1,153
+400
+53% +$103K 0.02% 630
2021
Q3
$213K Sell
753
-18
-2% -$5.9K 0.02% 649
2021
Q2
$267K Buy
+771
New +$234K 0.03% 565

Other funds holding BIIB

Independent Financial Group's BIIB Position: Q2 2026 in Review

Independent Financial Group increased its Biogen (BIIB) stake by 3.2% in Q2 2026, buying an estimated $31.8K and bringing the position to 5,364 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #629.

Independent Financial Group first reported a position in BIIB in Q2 2021 and has held it in 18 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Independent Financial Group held 5,364 shares of Biogen worth $1.16M as of Q2 2026.
  • Independent Financial Group bought 166 Biogen shares in Q2 2026, an estimated $31.8K.
  • Biogen made up 0.02% of Independent Financial Group's portfolio in Q2 2026, its #629 holding.
  • Independent Financial Group first reported a position in Biogen in Q2 2021 and has held it in 18 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.